Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, doubleblinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
De Jong, W., Aerts, J., Allard, S., Brander, C., Buyze, J., Florence, E., … Gruters, R. (2019). Correction to: iHIVARNA … Read More
